NEW YORK (GenomeWeb) – NGX Bio said today that it has raised $3 million, which it will use to further develop its business brokering deals between customers seeking next-generation sequencing and the facilities that provide it.

The funding round was led by 180 Degree Capital, and included Third Kind Venture Capital, Lateral Capital, the Band of Angels, and the Berkeley Angel Network, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.